Human Embryonic Stem Cell-Derived Neural Stem Cells Help Stroke Recovery
Author Information
Author(s): Daadi Marcel M., Maag Anne-Lise, Steinberg Gary K.
Primary Institution: Stanford University School of Medicine
Hypothesis
Can human embryonic stem cell-derived neural stem cells improve recovery in stroke models?
Conclusion
The SD56 human neural stem cells are stable, do not form tumors, and improve functional recovery after stroke.
Supporting Evidence
- The SD56 hNSCs showed a 37% survival rate and migrated towards stroke-damaged tissue.
- Transplantation of SD56 hNSCs improved the use of the impaired forelimb in stroke-injured rats.
- The hNSCs did not form tumors after implantation into rat brains.
Takeaway
Scientists found a special type of brain cell from human embryos that can help fix damage from strokes and make movement better.
Methodology
The study involved isolating a neural stem cell line from human embryonic stem cells and testing its effects in a stroke model in rats.
Potential Biases
Potential bias in the interpretation of results due to the experimental model used.
Limitations
The study was conducted in animal models, which may not fully replicate human conditions.
Participant Demographics
Rats were used in the study, specifically adult male Sprague Dawley rats.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website